US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist
  • 1.2100
  • +0.0900+8.04%
Close Nov 29 13:00 ET
  • 1.1700
  • -0.0400-3.31%
Post 17:01 ET
29.96MMarket Cap-477P/E (TTM)

Akari Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.16%-1.49M
-4.26%-4.89M
17.13%-4.04M
23.59%-16.43M
-4.41M
-2.45M
45.25%-4.69M
3.36%-4.88M
-14.10%-21.5M
-76.21%-8.57M
Net income from continuing operations
-0.84%-2.9M
-88.95%-7.56M
-656.04%-5.57M
43.61%-10.01M
---4.14M
---2.87M
29.58%-4M
119.34%1M
-1.86%-17.75M
-30.68%-5.68M
Operating gains losses
-179.41%-189K
127.97%167K
93.11%-385K
-28.91%-6.85M
---911K
--238K
-1,002.66%-597K
-6,679.83%-5.58M
-2,292.55%-5.32M
23.60%-54.14K
Depreciation and amortization
--0
--0
1,200.00%13K
0.00%4K
--1K
--1K
6.16%1K
-0.60%1K
-3.05%4K
-10.11%942
Other non cash items
----
----
----
--142K
----
----
----
----
----
----
Change In working capital
1,203.28%1.35M
648.66%2.05M
383.84%1.6M
-205.35%-866K
--193K
---122K
87.38%-374K
-615.08%-563K
141.44%822K
-457.39%-2.96M
-Change in prepaid assets
795.65%412K
1,980.00%564K
157.74%138K
-95.88%70K
--293K
--46K
93.56%-30K
46.03%-239K
197.52%1.7M
-450.96%-465.62K
-Change in payables and accrued expense
655.95%934K
532.56%1.49M
550.62%1.46M
-6.73%-936K
---100K
---168K
86.09%-344K
-158.68%-324K
-263.43%-877K
-272.24%-2.47M
Cash from discontinued investing activities
Operating cash flow
39.16%-1.49M
-4.26%-4.89M
17.13%-4.04M
23.59%-16.43M
---4.41M
---2.45M
45.25%-4.69M
3.36%-4.88M
-14.10%-21.5M
-76.21%-8.57M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-443K
2,567.70%7.76M
-52.86%1.51M
-72.24%7.02M
3.52M
0
291K
-74.03%3.21M
76.93%25.29M
0
Net issuance payments of debt
---336K
--669K
---215K
----
----
--0
--0
--0
----
----
Net common stock issuance
---133K
2,346.21%7.09M
-46.26%1.73M
-72.15%7.02M
--3.51M
--0
--290K
-74.03%3.21M
76.27%25.19M
--0
Proceeds from stock option exercised by employees
--26K
--0
--3K
-95.74%4K
--3K
--0
--1K
--0
--94K
----
Cash from discontinued financing activities
Financing cash flow
---443K
2,567.70%7.76M
-52.86%1.51M
-72.24%7.02M
--3.52M
--0
--291K
-74.03%3.21M
76.93%25.29M
--0
Net cash flow
Beginning cash position
-41.83%4.18M
-88.69%1.31M
-70.98%3.85M
41.54%13.25M
--4.73M
--7.18M
-30.74%11.58M
41.54%13.25M
-33.40%9.36M
150.78%16.72M
Current changes in cash
21.07%-1.93M
165.16%2.87M
-51.68%-2.53M
-348.73%-9.41M
---892K
---2.45M
48.65%-4.4M
-122.80%-1.67M
183.10%3.78M
-198.51%-8.57M
Effect of exchange rate changes
300.00%2K
-200.00%-2K
---5K
-93.33%7K
--6K
---1K
-16.81%2K
--0
174.61%105K
152.68%2.4K
End cash Position
-52.53%2.25M
-41.83%4.18M
-88.69%1.31M
-70.98%3.85M
--3.85M
--4.73M
-11.90%7.18M
-30.74%11.58M
41.54%13.25M
114.98%8.15M
Free cash flow
39.16%-1.49M
-4.26%-4.89M
17.13%-4.04M
23.59%-16.43M
---4.41M
---2.45M
45.25%-4.69M
3.36%-4.88M
-14.10%-21.5M
-76.21%-8.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.16%-1.49M-4.26%-4.89M17.13%-4.04M23.59%-16.43M-4.41M-2.45M45.25%-4.69M3.36%-4.88M-14.10%-21.5M-76.21%-8.57M
Net income from continuing operations -0.84%-2.9M-88.95%-7.56M-656.04%-5.57M43.61%-10.01M---4.14M---2.87M29.58%-4M119.34%1M-1.86%-17.75M-30.68%-5.68M
Operating gains losses -179.41%-189K127.97%167K93.11%-385K-28.91%-6.85M---911K--238K-1,002.66%-597K-6,679.83%-5.58M-2,292.55%-5.32M23.60%-54.14K
Depreciation and amortization --0--01,200.00%13K0.00%4K--1K--1K6.16%1K-0.60%1K-3.05%4K-10.11%942
Other non cash items --------------142K------------------------
Change In working capital 1,203.28%1.35M648.66%2.05M383.84%1.6M-205.35%-866K--193K---122K87.38%-374K-615.08%-563K141.44%822K-457.39%-2.96M
-Change in prepaid assets 795.65%412K1,980.00%564K157.74%138K-95.88%70K--293K--46K93.56%-30K46.03%-239K197.52%1.7M-450.96%-465.62K
-Change in payables and accrued expense 655.95%934K532.56%1.49M550.62%1.46M-6.73%-936K---100K---168K86.09%-344K-158.68%-324K-263.43%-877K-272.24%-2.47M
Cash from discontinued investing activities
Operating cash flow 39.16%-1.49M-4.26%-4.89M17.13%-4.04M23.59%-16.43M---4.41M---2.45M45.25%-4.69M3.36%-4.88M-14.10%-21.5M-76.21%-8.57M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -443K2,567.70%7.76M-52.86%1.51M-72.24%7.02M3.52M0291K-74.03%3.21M76.93%25.29M0
Net issuance payments of debt ---336K--669K---215K----------0--0--0--------
Net common stock issuance ---133K2,346.21%7.09M-46.26%1.73M-72.15%7.02M--3.51M--0--290K-74.03%3.21M76.27%25.19M--0
Proceeds from stock option exercised by employees --26K--0--3K-95.74%4K--3K--0--1K--0--94K----
Cash from discontinued financing activities
Financing cash flow ---443K2,567.70%7.76M-52.86%1.51M-72.24%7.02M--3.52M--0--291K-74.03%3.21M76.93%25.29M--0
Net cash flow
Beginning cash position -41.83%4.18M-88.69%1.31M-70.98%3.85M41.54%13.25M--4.73M--7.18M-30.74%11.58M41.54%13.25M-33.40%9.36M150.78%16.72M
Current changes in cash 21.07%-1.93M165.16%2.87M-51.68%-2.53M-348.73%-9.41M---892K---2.45M48.65%-4.4M-122.80%-1.67M183.10%3.78M-198.51%-8.57M
Effect of exchange rate changes 300.00%2K-200.00%-2K---5K-93.33%7K--6K---1K-16.81%2K--0174.61%105K152.68%2.4K
End cash Position -52.53%2.25M-41.83%4.18M-88.69%1.31M-70.98%3.85M--3.85M--4.73M-11.90%7.18M-30.74%11.58M41.54%13.25M114.98%8.15M
Free cash flow 39.16%-1.49M-4.26%-4.89M17.13%-4.04M23.59%-16.43M---4.41M---2.45M45.25%-4.69M3.36%-4.88M-14.10%-21.5M-76.21%-8.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data